KDIGO guidelines include FILSPARI for IgA nephropathy treatment
Go back to KDIGO guidelines include FILSPARI for IgA nephropathy treatment| CARLISLE COMPANIES, Inc. (NYSE: CSL) | Delayed: 340.99 +13.17 (4.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $327.82 | 52 Week High | $114.49 | |||
| Open | $332.71 | 52 Week Low | $75.17 | |||
| Day High | $342.26 | P/E | 94.46 | |||
| Day Low | $327.98 | EPS | $3.61 | |||
| Volume | 347,855 | |||||
| (AMEX: CSLLY) | Delayed: 19.14 +1.19 (6.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.95 | 52 Week High | $45.60 | |||
| Open | $18.88 | 52 Week Low | $33.39 | |||
| Day High | $19.23 | P/E | N/A | |||
| Day Low | $18.77 | EPS | $0.00 | |||
| Volume | 456,080 | |||||
| (NASDAQ: TVTX) | Delayed: 48.91 --48.91 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $ | |||
| Open | $0.00 | 52 Week Low | $ | |||
| Day High | $49.57 | P/E | N/A | |||
| Day Low | $46.54 | EPS | $ | |||
| Volume | 2,639,292 | |||||

